Electrolytes: Potassium and Sodium Balance, Hyponatremia and Hyperkalemia Basics

Potassium and sodium balance is supported by potassium-rich foods such as a medium banana (≈420 mg potassium), a medium baked potato (≈900 mg), avocado (≈485 mg per 100 g) and legumes, and normal laboratory ranges are serum potassium 3.5–5.0 mmol/L and serum sodium 135–145 mmol/L. For practical meal planning, common high-potassium choices include bananas, potatoes, tomatoes, spinach, oranges, beans, nuts and dairy; canned and processed foods often add sodium and alter the potassium-to-sodium ratio. Dietary potassium density varies by preparation, so portion sizes and cooking method (boiling leaches potassium) change actual intake. Clinicians commonly advise monitoring potassium intake when renal function is impaired or patients are prescribed RAAS inhibitors.

Homeostatic control of potassium and sodium balance operates through the Na+/K+ ATPase, aldosterone signaling and renal handling of electrolytes across nephron segments such as the proximal tubule, loop of Henle, distal convoluted tubule and cortical collecting duct. The renin–angiotensin–aldosterone system (RAAS) regulates sodium reabsorption and potassium secretion via mineralocorticoid receptor–mediated ENaC and ROMK channel activity, while the Na+/K+ pump sets the transmembrane gradient that determines cellular excitability. Clinical tools and methods used to assess status include serum electrolyte measurement, spot urine potassium or 24-hour urine potassium collection, and electrocardiography to detect hyperkalemia-related peaked T waves. Dietary sodium intake modifies renal potassium excretion and thus affects overall electrolyte homeostasis. Fractional excretion calculations and urine sodium testing are additional practical metrics.

A frequent misconception conflates sodium symptoms with potassium disorders; hyponatremia (serum sodium <135 mmol/L) produces cerebral edema and neurologic symptoms, whereas hyperkalemia (commonly defined as serum potassium >5.0 mmol/L; severe ≥6.5 mmol/L) primarily causes cardiac conduction abnormalities and muscle weakness. Clinicians and nutrition educators should note that high dietary potassium does not usually cause hyperkalemia in persons with normal glomerular filtration rate because renal potassium excretion and aldosterone-mediated mechanisms compensate; however, a concrete scenario of risk is chronic kidney disease stage 3–5 or use of ACE inhibitors, ARBs, spironolactone or potassium-sparing diuretics, where even modest increases in potassium foods can precipitate hyperkalemia. Hyponatremia management differs and often requires addressing free water balance rather than potassium restriction. Dietary guidance also varies by life stage, pregnancy and heart failure status.

Practical application integrates food selection with clinical context: prioritize high-potassium whole foods (bananas, potatoes, beans, leafy greens, avocados) for populations needing increased intake and monitor serum potassium and renal function when drugs that block the RAAS or potassium-sparing medications are used. Sodium intake should be individualized—lowering excess sodium can benefit blood pressure but alters renal potassium handling and may unmask hyponatremia in certain patients. Label-reading for potassium content aids informed choices and portion-awareness. Routine supplementation should follow laboratory confirmation and clinician guidance; this page contains a structured, step-by-step framework.